A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
NCT05866614 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 881
Last updated 2026-03-31
Summary
This is an observational, prospective cohort study to evaluate the safety of Remsima® SC in the treatment of RA, AS, PsA and Ps.
Conditions
Interventions
- DRUG
-
Remsima IV
Patient will be treated with Remsima IV as per the SmPC or
- DRUG
-
Remsima SC
Patient will be treated with Remsima SC as per the SmPC
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-13
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
- FDA Drug
- Yes
Countries
- France
Study Locations
More Related Trials
-
An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis
NCT02565810 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)
NCT03162796 ·Status: COMPLETED ·Phase: PHASE3
-
PoC in Rheumatoid Arthritis With Methotrexate
NCT00605735 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis
NCT01375478 ·Status: COMPLETED
-
A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
NCT01313858 ·Status: COMPLETED
-
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
NCT05049798 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
NCT05071664 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis
NCT00265096 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis
NCT00265083 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
NCT03158285 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
NCT03896581 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01232569 ·Status: COMPLETED ·Phase: PHASE3
-
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
NCT02159053 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan
NCT03348046 ·Status: COMPLETED
-
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
NCT04009499 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
NCT00051623 ·Status: COMPLETED ·Phase: PHASE3
-
Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy
NCT01490450 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
NCT02605642 ·Status: COMPLETED
-
Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement
NCT02721966 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00264550 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)
NCT01649817 ·Status: COMPLETED
-
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
NCT03120949 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
NCT05516758 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
NCT00254293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy
NCT00785928 ·Status: COMPLETED ·Phase: PHASE2